Silvercrest Asset Management Group LLC Cuts Position in Integer Holdings Co. (NYSE:ITGR)

Silvercrest Asset Management Group LLC cut its stake in shares of Integer Holdings Co. (NYSE:ITGR - Free Report) by 5.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 771,119 shares of the medical equipment provider's stock after selling 43,608 shares during the period. Silvercrest Asset Management Group LLC owned approximately 2.30% of Integer worth $102,189,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. Blue Trust Inc. grew its holdings in Integer by 4.4% during the 4th quarter. Blue Trust Inc. now owns 1,689 shares of the medical equipment provider's stock worth $220,000 after acquiring an additional 71 shares in the last quarter. Arizona State Retirement System grew its holdings in Integer by 0.9% during the 4th quarter. Arizona State Retirement System now owns 9,732 shares of the medical equipment provider's stock worth $1,290,000 after acquiring an additional 84 shares in the last quarter. HighPoint Advisor Group LLC grew its holdings in Integer by 6.4% during the 4th quarter. HighPoint Advisor Group LLC now owns 1,684 shares of the medical equipment provider's stock worth $234,000 after acquiring an additional 101 shares in the last quarter. Norden Group LLC grew its holdings in Integer by 7.0% during the 4th quarter. Norden Group LLC now owns 1,668 shares of the medical equipment provider's stock worth $221,000 after acquiring an additional 109 shares in the last quarter. Finally, Corient Private Wealth LLC grew its holdings in Integer by 6.4% during the 4th quarter. Corient Private Wealth LLC now owns 1,969 shares of the medical equipment provider's stock worth $261,000 after acquiring an additional 118 shares in the last quarter. 99.29% of the stock is currently owned by institutional investors and hedge funds.

Integer Stock Performance

Integer stock traded up $0.41 during trading hours on Monday, reaching $121.40. 403,168 shares of the stock were exchanged, compared to its average volume of 369,840. The stock has a market cap of $4.24 billion, a P/E ratio of 36.13, a P/E/G ratio of 1.72 and a beta of 1.03. The company has a debt-to-equity ratio of 0.62, a quick ratio of 2.09 and a current ratio of 2.95. Integer Holdings Co. has a 52-week low of $104.93 and a 52-week high of $146.36. The firm's 50 day moving average is $118.31 and its 200 day moving average is $129.51.

Integer (NYSE:ITGR - Get Free Report) last announced its quarterly earnings data on Thursday, April 24th. The medical equipment provider reported $1.31 EPS for the quarter, topping analysts' consensus estimates of $1.27 by $0.04. The company had revenue of $437.39 million during the quarter, compared to the consensus estimate of $428.51 million. Integer had a net margin of 6.92% and a return on equity of 11.65%. Integer's quarterly revenue was up 7.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.14 EPS. Analysts predict that Integer Holdings Co. will post 6.01 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research analysts have commented on ITGR shares. Truist Financial set a $150.00 price target on shares of Integer and gave the stock a "buy" rating in a report on Friday, April 25th. KeyCorp reduced their price objective on shares of Integer from $154.00 to $145.00 and set an "overweight" rating for the company in a research report on Monday, April 21st. Oppenheimer downgraded shares of Integer from an "outperform" rating to a "market perform" rating in a research report on Friday, February 21st. Raymond James boosted their price objective on shares of Integer from $145.00 to $150.00 and gave the stock an "outperform" rating in a research report on Friday, April 25th. Finally, StockNews.com upgraded shares of Integer from a "sell" rating to a "hold" rating in a research report on Monday. Three equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat, Integer has an average rating of "Moderate Buy" and a consensus target price of $145.56.

Insiders Place Their Bets

In other Integer news, CEO Joseph W. Dziedzic sold 338,975 shares of the company's stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $123.17, for a total transaction of $41,751,550.75. Following the completion of the transaction, the chief executive officer now owns 47,000 shares in the company, valued at approximately $5,788,990. This represents a 87.82% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 2.16% of the stock is owned by insiders.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.